Core Viewpoint - The article highlights the urgent need for improved management and treatment of drug-resistant tuberculosis (DR-TB) in China, emphasizing the high costs and significant patient burden associated with treatment, as well as the necessity for enhanced healthcare policies and collaboration among medical, insurance, and pharmaceutical sectors [3][4][5]. Group 1: Current Situation of Drug-Resistant Tuberculosis - Approximately 28,000 new patients are diagnosed annually with drug-resistant tuberculosis in China, with treatment costs ranging from 160,000 to 200,000 yuan, leading to a patient out-of-pocket expense of nearly 100,000 yuan after insurance reimbursement [3][4]. - China is projected to enter the category of countries with low tuberculosis prevalence by 2024, yet it still accounts for 7.1% of the global new cases of multi-drug resistant tuberculosis [3][4]. Group 2: Challenges in Treatment - The treatment regimen for drug-resistant tuberculosis is lengthy, lasting 18 to 24 months, and often has a low success rate of 50% to 75%, exacerbated by high costs and complex medication protocols [5][6]. - The high prevalence of drug-resistant tuberculosis is particularly concerning in regions with limited healthcare resources, where elderly patients with comorbidities are increasingly common, further complicating treatment adherence [5][6]. Group 3: Proposed Solutions - A proposed solution includes the implementation of low-cost, locally developed treatment options, as demonstrated by the Trust program in Guizhou, which has improved treatment adherence among patients [5][6]. - Recommendations for improving patient care include integrating drug-resistant tuberculosis into special disease management programs, adjusting payment standards based on disease type, and enhancing the accessibility of essential medications through insurance reforms [7][8]. Group 4: Legislative and Policy Framework - The recent revision of the Infectious Disease Prevention Law elevates tuberculosis prevention efforts to a national legal framework, indicating a shift towards more comprehensive and enforceable regulations [8]. - Experts advocate for increased financial investment and the establishment of special funds to support drug-resistant tuberculosis treatment, aiming for a model where patients face zero out-of-pocket costs for necessary medications [8].

Core Viewpoint - The article emphasizes the importance of strengthening public health capabilities in China, particularly in the context of infectious disease prevention and control, as highlighted by government officials during the recent National People's Congress sessions [3][4]. Group 1: Public Health Strategy - The National Health Commission's director, Lei Haichao, outlined four key areas for public health work over the next five years, including enhancing public health safety capabilities and building a global health community [3]. - The "14th Five-Year Plan" aims to establish a robust and intelligent public health protection network centered on people's health [3][5]. Group 2: Infectious Disease Control - The shift in focus from "key infectious disease prevention" to a broader public health framework reflects the need for a stronger public health system as the first line of defense for people's health [5]. - The new Infectious Disease Prevention Law, implemented last year, aims to enhance the response to public health emergencies and improve the overall infectious disease control capabilities [5]. Group 3: Collaborative Mechanisms - There is an expectation for deeper collaboration among various departments to improve public health capabilities, moving from individual accountability to a collective health accounting approach [7]. - The integration of medical and preventive measures is crucial, with an emphasis on vaccination as a cost-effective public health intervention [7]. Group 4: Innovation and Development - Lei Haichao stressed the need for more vaccines and better testing methods to enhance self-sufficiency in infectious disease control [8]. - Industry experts anticipate increased support for the development and commercialization of innovative products, including multi-valent vaccines, during the "14th Five-Year Plan" period [8].

Group 1 - Bill Gates, chairman of the Gates Foundation, unexpectedly appeared in Shanghai on February 11 for an event titled "Action Creates Hope" focusing on global health and development issues [1] - Gates' visit aims to understand the latest progress of Chinese partners in key areas such as infectious disease prevention, maternal and child health, and agriculture [1] - The discussion will explore how to better apply relevant experiences and technologies to the international community, primarily composed of low- and middle-income countries, to achieve tangible results in global health and development [1] - This visit marks Gates' return to China approximately two and a half years after his last visit in June 2023 [1]

Core Viewpoint - The article emphasizes the increased risk of respiratory infectious diseases during the Spring Festival period in February due to heightened human mobility and gatherings, alongside recommendations for prevention measures. Group 1: Respiratory Infectious Diseases - The winter-spring season is a peak period for acute respiratory infectious diseases in China, with influenza and respiratory syncytial virus being the main pathogens identified [1] - Current monitoring indicates a general decline in respiratory infectious diseases, but they remain prevalent during the flu season [1] Group 2: Recommendations for Prevention - Maintain good hygiene practices, such as covering the mouth and nose when coughing or sneezing, frequent handwashing, and avoiding contact with individuals showing flu-like symptoms [2] - Individuals with respiratory symptoms should avoid crowded places and wear masks during travel [2] - Vaccination is the most effective means of preventing influenza, especially for vulnerable groups like pregnant women, young children, the elderly, and those with chronic diseases [2] Group 3: Avian Influenza - Human infection with avian influenza is an acute respiratory disease caused by the avian influenza virus, with symptoms including fever, cough, and muscle pain, and severe cases may lead to acute respiratory distress syndrome [3][4] - Direct contact with infected birds or contaminated environments is the primary transmission route [4] Group 4: Norovirus and Foodborne Illnesses - Norovirus gastroenteritis is highly contagious and can spread through contaminated food or water, with symptoms including nausea, vomiting, and diarrhea [7] - The risk of foodborne illnesses increases during the Spring Festival due to family gatherings and food handling practices [9] Group 5: Carbon Monoxide Poisoning - The period from November to March sees a rise in carbon monoxide poisoning cases, particularly during the Spring Festival when families may use coal or charcoal for heating [12] - Symptoms of poisoning include headache, dizziness, and nausea, which can be life-threatening in severe cases [12] Group 6: Mosquito-borne Diseases - Travelers to tropical and subtropical regions during the Spring Festival should be aware of mosquito-borne diseases such as dengue fever and Zika virus [16] - Preventive measures include using mosquito repellent and wearing protective clothing [15] Group 7: Nipah Virus - Nipah virus disease is a zoonotic infection primarily transmitted through contact with infected animals or contaminated food [16] - Travelers are advised to avoid contact with bats and potentially contaminated food, and to seek medical attention if symptoms arise after travel [18]

Group 1 - The World Health Organization (WHO) reported a case of Nipah virus infection in Bangladesh, with the infected individual being a woman aged between 40 and 50 from the Rajshahi region, who showed symptoms on January 21 and was diagnosed on January 29 [1] - The infected woman had no recent travel history but consumed raw date palm juice, and all 35 close contacts tested negative for the virus [1] - Bangladesh frequently experiences small-scale outbreaks of Nipah virus, particularly between December and April, coinciding with the harvesting and consumption season of date palm juice [1] Group 2 - Nipah virus is classified as a high-fatality zoonotic virus, with a mortality rate ranging from 40% to 75%, and there is currently no specific vaccine or effective treatment available [2] - The virus can be transmitted through infected animals, contaminated food or environments, and in rare cases, through direct human-to-human contact [4] - Consumption of raw date palm juice is a significant transmission route, as it can be contaminated by fruit bats, which are the primary carriers of the virus [4]

Group 1 - The National Health Commission and other authorities have issued a notice to ensure the prevention and control of infectious diseases during the 2026 Spring Festival, emphasizing the need for local departments to implement detailed measures to maintain overall pandemic stability and ensure public health during the holiday [1] - Increased cross-border and inter-regional movement during the Spring Festival poses a heightened risk of disease transmission, necessitating enhanced monitoring of various infectious diseases, including COVID-19, monkeypox, dengue fever, and others [1] - The notice outlines specific guidelines for educational institutions, elderly care facilities, transportation hubs, and food service providers to ensure health and safety measures are in place [1] Group 2 - There is a continuous push for high-risk groups, such as children, the elderly, and patients with chronic diseases, to actively receive flu vaccinations, along with efforts to improve vaccination services [2] - The current infectious disease situation in China is generally stable, with COVID-19 at low levels and flu cases decreasing, although acute respiratory infections remain a concern during the high season [2] - Risks from imported mosquito-borne diseases like dengue and chikungunya persist, particularly in warmer southern regions, while there is a potential for outbreaks of gastrointestinal infections in schools and childcare facilities after the holiday [2]

Core Viewpoint - The National Health Commission and other authorities have issued a directive to enhance the prevention and control of infectious diseases ahead of the 2026 Spring Festival, emphasizing the need for local departments to implement detailed measures to ensure public health and safety during the holiday period [1][2]. Group 1: Infectious Disease Prevention Measures - Authorities are focusing on the prevention of imported infectious diseases, closely monitoring global situations regarding COVID-19, monkeypox, dengue fever, chikungunya, malaria, and new subtypes of influenza [1][2]. - There is a requirement for epidemiological investigations of new infectious disease cases among incoming travelers, tracking and managing close contacts to prevent the spread of diseases [1]. - Guidelines are provided for various institutions, including schools and elderly care facilities, to ensure hygiene and health monitoring, as well as for transportation and food service sectors to enhance safety measures [1][2]. Group 2: Vaccination and Healthcare Services - There is an ongoing effort to promote flu vaccinations among high-risk groups such as children, the elderly, and patients with chronic diseases, along with optimizing vaccination services [2]. - Areas with weak routine immunization are being targeted for catch-up vaccinations, particularly in response to measles outbreaks [2]. - The overall infectious disease situation in the country is stable, with COVID-19 at low levels and flu at medium to low levels, although there are risks of imported cases of mosquito-borne diseases and potential outbreaks in specific settings like schools and dining establishments [2].

Core Viewpoint - During the "14th Five-Year Plan" period, Beijing's disease control system will enhance various infectious disease monitoring and early warning systems, focusing on vector-borne diseases and improving response capabilities to prevent local transmission of imported infectious diseases [1][2]. Group 1: Key Initiatives in Disease Control - The Beijing CDC will optimize monitoring and early warning systems for respiratory, intestinal, and vector-borne diseases, and enhance monitoring and control of mosquito and tick-borne diseases [1]. - The establishment of the Capital Public Health Center and the promotion of coordinated governance of allergens and vector-borne diseases are highlighted as key areas of focus [1]. - The Beijing CDC aims to strengthen the overall effectiveness of the disease control system by providing ongoing guidance to district-level disease control in areas such as infectious disease and chronic disease prevention, monitoring, and emergency response [2]. Group 2: Influenza Situation and Response - Influenza activity in Beijing began to rise significantly from October last year, with the flu season starting in week 46 of 2025, four weeks earlier than the previous season [4]. - The peak positivity rate for influenza in sentinel hospitals reached 62.66%, indicating a relatively high intensity of the current flu season, although the number of visits to fever clinics was lower than in previous seasons [4][11]. - The Beijing CDC has integrated winter respiratory disease prevention into routine risk management, covering 22 key pathogens and utilizing a comprehensive monitoring network [3]. Group 3: Variants and Public Health Strategies - The main circulating strain in Beijing is the H3N2 subtype of the influenza A virus, which has undergone minor antigenic drift, potentially affecting vaccine efficacy [8]. - The CDC emphasizes the importance of different prevention strategies for various respiratory pathogens, with influenza being seasonal and manageable through vaccination and antiviral medications [10]. - The decline in patient visits despite rising positivity rates is attributed to improved public health measures and increased accessibility to medical resources, leading to a "no-symptom" approach to disease management [12]. Group 4: Vaccination Efforts - As of the 2025 flu season, 2.3346 million flu vaccines have been administered in Beijing, a 10% increase from the previous year, with coverage among key populations exceeding last year's figures [14]. - The city has provided free flu vaccinations to schoolchildren and seniors since 2007, achieving a fourfold increase in coverage compared to the self-paid period, with an average coverage rate of over 55% among schoolchildren in recent years [14]. - The Beijing CDC plans to leverage artificial intelligence for research on flu variant prediction and vaccine effectiveness in the upcoming year [15].

Core Viewpoint - The Shanghai Municipal Health Commission and the Municipal Center for Disease Control and Prevention announced the implementation status of the sixth round of the three-year action plan for strengthening public health system construction (2023-2025), which aims to enhance public health safety and serve as a national model [1] Group 1: Key Projects and Goals - The current plan focuses on "capacity enhancement" with goals to "address shortcomings, strengthen weaknesses, and increase capabilities" through 13 collaborative projects [1] - Four major engineering projects are prioritized: emergency capacity, service capacity, collaborative capacity, and guarantee capacity [2] Group 2: Emergency and Service Capacity - Emergency capacity improvements include the establishment of an intelligent infectious disease monitoring and early warning system, and the development of a clinical diagnosis and treatment center for infectious diseases [2] - Service capacity enhancements involve optimizing the layout of disease control laboratories and creating a platform for infectious disease prevention and health promotion [2] Group 3: Collaborative and Guarantee Capacity - Collaborative capacity focuses on building a data management model for common diseases in children and adolescents, and establishing demonstration communities for chronic infectious disease management [2] - Guarantee capacity includes the development of a public health training system and the cultivation of key disciplines and talent teams [2] Group 4: Achievements in Disease Control - The Shanghai disease control center has established a closed-loop system for infectious disease monitoring, warning, and response, achieving full data collection and a dual-track monitoring model [3] - AI early warning models can predict epidemics and medical burdens two weeks in advance, with accuracy at the street and town level [3] Group 5: Biological Safety and Monitoring - Breakthroughs in pathogen detection and tracing have been achieved, with a digital information database for biological samples that can identify unknown pathogens within 48 hours [3] - A comprehensive monitoring network covering humans, animals, and the environment has been established, enhancing the monitoring of antibiotic resistance genes and airborne microorganisms [3]

Core Insights - Shanghai has enhanced its public health system through a three-year action plan (2023-2025), focusing on improving risk prevention capabilities in a densely populated urban environment [1][3] Monitoring Network - Shanghai optimized the monitoring efficiency of 354 fever clinics and 227 intestinal clinics, added 7 children's comprehensive monitoring points, and expanded 8 media information monitoring sources [1] - The city deployed integrated equipment for vector monitoring, achieving real-time dynamic monitoring of mosquitoes, and upgraded 523 medical institutions with intelligent reporting plugins, reducing reporting time by 50% [1] Intelligent Early Warning - Shanghai has innovated a meteorological-infectious disease risk forecasting technology, which has been recognized as a city demonstration case by the World Health Organization [2] - The city established a modular layout standard for large emergency response sites and a comprehensive emergency operation center (EOC) that integrates real-time information gathering and risk assessment [2] Testing and Detection - The Shanghai CDC has achieved rapid identification of over 200 known pathogens within 24 hours and rapid localization of unknown pathogens within 48 hours [2] - A public health pathogen laboratory network has been established, enabling a transition from routine to emergency testing for special pathogens within 36 hours [2] Data Integration and Analysis - Shanghai developed a cloud-based comprehensive analysis system for pathogen monitoring data, allowing real-time tracking and early warning of the entire process from sample collection to testing [4] - The system integrates IoT and geographic positioning technologies, facilitating the rapid identification of unknown pathogens within 48 hours and precise tracing of samples within 24 hours [4] Biomedicine Innovation - Shanghai has built an organoid research platform to support vaccine development and drug screening, accelerating biomedicine innovation and ensuring biosecurity across critical urban operations [4]